Deutsche Bank Ag\ Orchard Therapeutics PLC Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$4.39 - $9.08 $6,018 - $12,448	-1,371 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.86 - $5.07 $5,284 - $6,940	1,369 Added 68450.0%	1,371 $6,000
Q2 2020 Aug 13, 2020	BUY	$5.75 - $11.99 $11 - $23	2 New	2 $0
Q1 2020 May 14, 2020	SELL	$5.65 - $15.71 $6,525 - $18,145	-1,155 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$10.15 - $15.58 $11,723 - $17,994	1,155 New	1,155 $15,000
Q3 2019 Nov 14, 2019	SELL	$11.88 - $16.72 $4,752 - $6,688	-400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.63 $5,280 - $8,252	400 New	400 $5,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.